ProPhase Labs, Inc.: Form 10-Q/A for the period ended Mar 31, 2017
Filed with the SEC on Aug 20, 2018 and accepted by EDGAR at Aug 20, 2018, 20:44 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $771.0k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $686.0k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-01-01 to 2017-03-31 | $85.0k | us-gaap:GrossProfit |
| Research and development | 3 months2017-01-01 to 2017-03-31 | $34.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | −$745.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-01-01 to 2017-03-31 | $54.0k | us-gaap:InterestExpense |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $453.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | $43.9m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2017-01-01 to 2017-03-31 | 17,772,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2017-01-01 to 2017-03-31 | $3.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2017-01-01 to 2017-03-31 | $42.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-03-31 | $42.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $49.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $57.5m | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $7.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2017-03-31 | $49.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-18-012354. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.